Cited by 175Gut microbiota and healthChronic Kidney Disease and DiabetesMetabolomics and Mass Spectrometry Studies

Gut-Microbiota-Metabolite Axis in Early Renal Function Decline

Open access
Barrios, Clara, Beaumont, Michelle, Pallister, Tess, Villar, Judith, Goodrich, Julia K., Clark, Andrew, Pascual, Julio, Ley, Ruth E. +3 more·2015·PLOS ONE

Abstract

INTRODUCTION: Several circulating metabolites derived from bacterial protein fermentation have been found to be inversely associated with renal function but the timing and disease severity is unclear. The aim of this study is to explore the relationship between indoxyl-sulfate, p-cresyl-sulfate, phenylacetylglutamine and gut-microbial profiles in early renal function decline. RESULTS: Indoxyl-sulfate (Beta(SE) = -2.74(0.24); P = 8.8x10-29), p-cresyl-sulfate (-1.99(0.24), P = 4.6x10-16), and phenylacetylglutamine(-2.73 (0.25), P = 1.2x10-25) were inversely associated with eGFR in a large population base cohort (TwinsUK, n = 4439) with minimal renal function decline. In a sub-sample of 855 individuals, we analysed metabolite associations with 16S gut microbiome profiles (909 profiles, QIIME 1.7.0). Three Operational Taxonomic Units (OTUs) were significantly associated with indoxyl-sulfate and 52 with phenylacetylglutamine after multiple testing; while one OTU was nominally associated with p-cresyl sulfate. All 56 microbial members belong to the order Clostridiales and are represented by anaerobic Gram-positive families Christensenellaceae, Ruminococcaceae and Lachnospiraceae. Within these, three microbes were also associated with eGFR. CONCLUSIONS: Our data suggest that indoxyl-sulfate, p-cresyl-sulfate and phenylacetylglutamine are early markers of renal function decline. Changes in the intestinal flora associated with these metabolites are detectable in early kidney disease. Future efforts should dissect this relationship to improve early diagnostics and therapeutics strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0134311

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Centenarians have enrichment of Akkermansia, Bifidobacterium, and Christensenellaceae in their intestinal flora, which promote positive immune function, have anti-inflammatory activity, diminish effects of obesity, and contribute to metabolic homeostasis.

    “Centenarians, who can be considered extreme examples of healthy ageing, have an enrichment of Akkermansia, Bifidobacterium, and Christensenellaceae in their intestinal flora67, which promote positive immune function, have anti-inflammatory activity, diminish the effects of obesity, and contribute to metabolic homeostasis77–79.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 38 · Cited by 175

Authors
Barrios, C., Beaumont, M., Pallister, T., Villar, J., Goodrich, J. K., Clark, A., Pascual, J., Ley, R. E., Spector, T. D., Bell, J. T., & Menni, C.
Affiliations
  • King's College London (GB)
  • Hospital Del Mar (ES)
  • Cornell University (US)
Corresponding author
  • Barrios, Clara
  • Menni, Cristina
Venue
PLOS ONE
Published
2015-08-04
Volume
10
Issue
8
Pages
e0134311
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1855748361
Cited by
175
References
38
Citations by year
2026: 10 · 2025: 15 · 2024: 23 · 2023: 18 · 2022: 20 · 2021: 19 · 2020: 23 · 2019: 16 · 2018: 13 · 2017: 9 · 2016: 9
FWCI
4.49
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (FP7/2007–2013)
  • Sociedad Española de Nefrología
  • National Institute for Health and Care Research (FP7/2007–2013)
  • King's College London
  • National Institute of General Medical Sciences (T32GM007617)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
gut microbiota, microbial metabolites, indoxyl sulfate, p-cresyl sulfate, phenylacetylglutamine, estimated glomerular filtration rate, kidney disease biomarkers, Clostridiales, Christensenellaceae, Ruminococcaceae, Lachnospiraceae
MeSH terms
Eubacteriales, Clostridiales, Gastrointestinal Microbiome, Adult, Aged, Aged, 80 and over, Cresols, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diseases in Twins, Feces, Female, Fermentation, Glomerular Filtration Rate, Glutamine, Humans, Indican, Kidney Diseases, Male, Middle Aged, Sulfuric Acid Esters, Body Mass Index, Ribotyping, Metabolome, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review